Clearance Summary
Rapid2 Magnetic Stimulators (Magstim Rapid2, Magstim Super Rapid2, Magstim Super Rapid2 Plus1) received FDA 510(k) clearance under submission number K250286, sponsored by The Magstim Company Limited. The device was reviewed via the Traditional premarket notification pathway and assigned to the Neurology review panel. The statutory decision date of record is 2025-07-03.
- Submission: K250286
- Applicant / Sponsor: The Magstim Company Limited
- Clearance pathway: Traditional
- Review panel: Neurology
- Device class: Class II
- Regulation citation: 21 CFR 882.5890
- Decision date: 2025-07-03
Classification & Regulation
This clearance is catalogued under FDA product code QPL and 21 CFR 882.5890, within the Neurology review panel as a Class II device.